intralinks holdings inc (IL) Key Developments
Intralinks Holdings, Inc. Appoints Thor S. Johnson as Chief Marketing Officer
Jul 9 14
Intralinks Holdings, Inc. announced the appointment of Thor Johnson to the role of chief marketing officer. Reporting to chief executive officer Ronald Hovsepian and a member of the Intralinks executive leadership team, Johnson will have overall responsibility for the company's marketing strategy and execution. Johnson brings to Intralinks more than three decades of marketing technology experience and is an expert in branding and positioning, marketing analytics, sales operations and multi-channel demand generation. Most recently, Johnson was CEO of his own marketing consulting firm, which provided services including sales/marketing alignment strategy, creative campaign development and technology implementation.
IntraLinks Expands European Operations to Meet Growing Demand
Jun 23 14
IntraLinks Holdings announced that it plans to expand its European operations to meet growing demand for the company's secure enterprise collaboration solutions. IL has moved its European headquarters in London to new offices that will accommodate this expansion and is actively recruiting for a variety of positions that will help grow the business and support new and existing customers.
Intralinks Holdings, Inc. Announces Availability of its Electronic Investigator-Controlled Site File Solution
Jun 10 14
Intralinks Holdings, Inc. announced the availability of its electronic investigator-controlled site file solution, a simple online document storage tool for investigator sites involved in the clinical trial process. The new solution is designed to dramatically improve regulatory compliance and efficiency at the investigator site while revolutionizing how sponsors can maintain oversight of participant sites by enabling study monitors and inspectors to no longer have to view investigator documents in person. In the last decade, life science companies have invested heavily in electronic trial master file systems and other workflow and document management tools to improve the collection, filing and submission of all relevant clinical study documentation. However, eTMF technology and processes are focused on the trial sponsor and driven by study milestones. These systems are poorly suited for extension to investigator sites because regulations require that each site involved in a clinical trial maintain their own independent study binders in order to provide confirmation of the sponsor's conduct, compliance and the integrity of the trial. Investigator sites must maintain full control over their investigator site file, and even decades after the trial is over the sponsor must ensure that agreements are in place to ensure the availability of these binders for inspection without ever having uncontrolled access. As a result, over 80% of site-based documentation is still fully paper-based with both cost and risk consequences for the entire clinical trial process.
IntraLinks Holdings, Inc. Presents at 11th Annual Craig-Hallum Institutional Investor Conference, May-28-2014 02:50 PM
May 26 14
IntraLinks Holdings, Inc. Presents at 11th Annual Craig-Hallum Institutional Investor Conference, May-28-2014 02:50 PM. Venue: Minneapolis Marriott City Center Hotel, 30 South Seventh Street, Minneapolis, MN 55402, United States.
IntraLinks Holdings, Inc. Appoints Javier Colado as President of Asia Pacific
May 8 14
IntraLinks Holdings, Inc. announced the appointment of Javier Colado as the company's president of Asia Pacific. Colado brings a wealth of experience running international sales organizations, most recently as managing director for Spain and Portugal at SAP. Prior to SAP, he led worldwide sales for Novell and also served as president for Europe, the Middle East and Africa and as channel chief, helping expand into South America and Eastern Europe. Mr. Colado will be based out of Singapore.